Cargando…
Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease
Autores principales: | Higham, Andrew, Beech, Augusta, Wolosianka, Sophie, Jackson, Natalie, Long, Gabriella, Kolsum, Umme, Southworth, Thomas, Pham, Tuyet‐Hang, Sridhar, Sriram, McCrae, Christopher, Newbold, Paul, Singh, Dave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247000/ https://www.ncbi.nlm.nih.gov/pubmed/33206402 http://dx.doi.org/10.1111/all.14661 |
Ejemplares similares
-
The relationship between airway immunoglobulin activity and eosinophils in COPD
por: Southworth, Thomas, et al.
Publicado: (2020) -
Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease
por: Higham, Andrew, et al.
Publicado: (2022) -
The stability of blood Eosinophils in chronic obstructive pulmonary disease
por: Long, Gabriella H., et al.
Publicado: (2020) -
Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
por: Kolsum, Umme, et al.
Publicado: (2017) -
Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases
por: Sridhar, Sriram, et al.
Publicado: (2019)